• Ticker

DJIA 12,801.23 -89.23 -0.69%
NASDAQ 2,903.88 -23.35 -0.80%
S&P 500 1,342.64 -9.31 -0.69%
Maintenance Notification

Quotes and Portfolios will be down on Sunday February 12, 2012 from 2 AM to 4 AM while we perform maintenance on the site. We apologize for the inconvenience.

$47.91 -$0.58 (-1.20%)

Quote as of 4:02 PM EST on 02/10/12

Valeant Pharmaceuticals Intern...

NYSE:VRX

Mylan Acquires Two Generics

2/8/2012 by Zacks Equity Research Analyst Blog

Mylan Acquires Two Generics - Analyst Blog

2/8/2012 by Zacks Investment Research

Mylan Buys Two Dermatology Drugs from Valeant

2/6/2012 by Drug Discovery & Development

Valeant withdraws acquisition offer for Ista

1/30/2012 by Drug Store News

Ista board updates strategic review process

1/30/2012 by Theflyonthewall.com

Valeant Includes OTCs In Bid For Dramatic Growth By 2013

1/23/2012 by Health Care Business Intelligence

Where To Invest: Valeant Pharma Rises, Outlook Good

1/18/2012 by Investor's Business Daily

Valeant Ups ISTA Bid

1/18/2012 by Zacks Equity Research Analyst Blog

Valeant raises offer for Ista Pharmaceuticals(2)

1/17/2012 by Pharmaceutical Processing

Valeant Hikes Offer for Drug Maker Ista

1/17/2012 by Orange County Business Journal

Salix, Valeant Display Possible Entry Points

1/11/2012 by Investor's Business Daily

Valeant Provides 2012 Roadmap - Analyst Blog

1/10/2012 by Zacks Investment Research

Valeant Provides 2012 Roadmap

1/10/2012 by Zacks Equity Research Analyst Blog
See More Articles...